S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Voyager Therapeutics (VYGR) Insider Trading & Ownership

$7.50
-0.05 (-0.66%)
(As of 04/19/2024 08:51 PM ET)

Voyager Therapeutics (NASDAQ:VYGR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$267,185.66
Get VYGR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Voyager Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VYGR Insider Buying and Selling by Quarter

Voyager Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/17/2024Robin SwartzCOOSell2,543$7.15$18,182.45  
1/17/2024Todd Alfred CarterInsiderSell1,266$7.18$9,089.88  
10/3/2023Peter P PfreundschuhCFOSell13,567$6.99$94,833.33  
9/15/2023Todd Alfred CarterInsiderSell10,500$8.16$85,680.00  
7/6/2023Todd Alfred CarterInsiderSell5,500$10.80$59,400.00  
(Data available from 1/1/2013 forward)

VYGR Insider Trading Activity - Frequently Asked Questions

Who is on Voyager Therapeutics's Insider Roster?

The list of insiders at Voyager Therapeutics includes Alfred Sandrock, Ecor1 Capital, Llc, Glenn Pierce, Julie Burek, Neurocrine Biosciences Inc, Peter P Pfreundschuh, Robert W Hesslein, Robin Swartz, Rock Ventures Iii L.P. Third, and Todd Alfred Carter. Learn more on insiders at VYGR.

What percentage of Voyager Therapeutics stock is owned by insiders?

4.70% of Voyager Therapeutics stock is owned by insiders. Learn more on VYGR's insider holdings.

Which Voyager Therapeutics insiders have been buying company stock?

The following insiders have purchased VYGR shares in the last 24 months: Ecor1 Capital, Llc ($2,663,552.00), and Neurocrine Biosciences Inc ($39,032,821.44).

How much insider buying is happening at Voyager Therapeutics?

Insiders have purchased a total of 4,872,988 VYGR shares in the last 24 months for a total of $41,696,373.44 bought.

Which Voyager Therapeutics insiders have been selling company stock?

The following insiders have sold VYGR shares in the last 24 months: Alfred Sandrock ($58,231.71), Ecor1 Capital, Llc ($4,432,520.00), Glenn Pierce ($63,730.40), Peter P Pfreundschuh ($94,833.33), Robert W Hesslein ($102,333.61), Robin Swartz ($56,395.46), Rock Ventures Iii L.P. Third ($8,064,906.08), and Todd Alfred Carter ($193,692.75).

How much insider selling is happening at Voyager Therapeutics?

Insiders have sold a total of 1,731,264 Voyager Therapeutics shares in the last 24 months for a total of $13,066,643.34 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:VYGR) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners